The tool analyzes results from standard tests of organ function, tumor burden, and inflammation to predict whether lymphoma patients will respond to treatment.

Like a creature from a science fiction movie, chronic lymphocytic leukemia (CLL) can be a shape-shifter. In a small number of ...

Scientists have discovered how aging blood stem cells acquire mutations that give them a growth edge, creating fertile ground for the development of clonol hematopoiesis, a condition that dramatically ...

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...

3 Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, China 4 The Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, China ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

For this purpose, we fused the PE38 toxin with the specific C5 sdAb antibody, previously developed by our group for canine B-cell lymphoma. This resulted in a stable and highly specific C5-PE38 ...

Non-Hodgkin's lymphoma (NHL) occurs when lymphocytes called ... the appearance of the lymph nodes and cells, and the number of cells in the blood. The cancer will be assigned a stage grouping between ...

It is one of two types of lymphoma - cancers that start in white blood cells and are important for your immune system. With non-Hodgkin lymphoma, genes inside B lymphocytes - the B cells or T ...

Cord blood as a source of stem cells offers many benefits over bone marrow and peripheral blood: It is stored in cord blood banks after collection and is available on demand, reducing the wait time ...